Clinical
QIAGEN Bioinformatics // Monday, July 8, 2019

Using liquid biopsy to guide clinical trial enrollment for patients with cancer

Investigators in the UK are using QIAGEN Clinical Insight (QCI) to identify clinically actionable mutations from blood-based sequencing results On…


Clinical
QIAGEN Bioinformatics // Thursday, June 27, 2019

Discover more disease-causing mutations with the HGMD Summer ’19 release

  We are happy to announce the Summer ’19 Release of the Human Gene Mutation Database (HGMD) Professional is now…


Clinical
QIAGEN Bioinformatics // Monday, June 24, 2019

QIAGEN Clinical Insight surpasses 1 million patient test cases analyzed and interpreted

READ PRESS RELEASE   We are proud to announce that QIAGEN Clinical Insight (QCI®), QIAGEN’s clinical decision support platform has…


Clinical
QIAGEN Bioinformatics // Saturday, June 1, 2019

Lab performing expanded carrier screening boosts efficiency by 80%

A high-throughput population screening laboratory sees significant scale-up with implementation of QIAGEN Clinical Insight (QCI®)   INTRODUCTION Genetic disease is the…


Clinical
QIAGEN Bioinformatics // Wednesday, May 29, 2019

Curating the Clinical Genome 2019, Washington, DC

2019 Curating the Clinical Genome Wrap-Up The 2019 Curating the Clinical Genome Conference was a remarkable event this year. A…


Clinical
Discovery
Leif Schauser // Tuesday, May 21, 2019

How to accurately quantify miRNAs and increase fraction of annotated reads

Introduction to the QIAseq miRNA library kit support in the Biomedical Genomics Analysis plugin for CLC Genomics Workbench The QIAseq…


Clinical
QIAGEN Bioinformatics // Wednesday, April 3, 2019

HGMD 2019.1 hits major milestone

Over a quarter million germline mutations catalogued   HGMD now contains 256,070 germline mutations As of March 29, 2019, HGMD…


Clinical
QIAGEN Bioinformatics // Monday, February 4, 2019

New momentum for harmonizing TMB results

As more research emerges surrounding the standardization of tumor mutational burden (TMB) assessment, a universal definition of “high TMB” across…


Clinical
QIAGEN Bioinformatics // Sunday, February 3, 2019

QIAGEN Conversations

Sean Scott, QIAGEN’s Chief Business Officer and Vice President of Business Development for Clinical Genomics and Bioinformatics, discusses the N-of-One…


Clinical
QIAGEN Bioinformatics // Wednesday, January 30, 2019

Driving real-world impact with N-of-One, now a QIAGEN company

QIAGEN acquires N-of-One, expanding its clinical bioinformatics capabilities in molecular oncology decision support We are excited to announce our acquisition N-of-One,…


Clinical
QIAGEN Bioinformatics // Wednesday, December 5, 2018

Kick Start Your New Year with HGMD Professional 2018.4!

HGMD® Professional version 2018.4 contains a total of 248,700 mutations entries—that’s 8,431 more mutation entries than the previous release! Unlike other…


Clinical
QIAGEN Bioinformatics // Saturday, December 1, 2018

QIAGEN launches QCI Interpret bioinformatics features for blood cancers

Introducing a novel myeloid gene panel for the GeneReader NGS System with integrated variant analysis, interpretation and reporting from QIAGEN…

© QIAGEN 2019. All rights reserved - Trademarks & Disclaimers